Dr. Bradley Heltemes, VP and medical director of R&D at Munich Re Life US, and Dr. Tim Meagher, Vice President and Medical Director Munich Re, Canada (Life) discuss how AI and technology are playing a more prominent role in the life insurance sector and improving cancer patient outcomes.
Leave a Reply